Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Euro Surveill ; 29(32)2024 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-39119719

RESUMO

BackgroundA new respiratory virus surveillance platform, based on nationwide hospital laboratory data, was established in Israel during the COVID-19 pandemic.AimWe aimed to evaluate the performance of this platform with respect to the detection of influenza and respiratory syncytial virus (RSV) from week 36 in 2020 to week 15 in 2023, and how it fits with the World Health Organization (WHO) mosaic surveillance framework.MethodsData of respiratory samples from hospitalised patients sent for laboratory confirmation of influenza virus or RSV from 25 general hospital laboratories nationwide were collected. We analysed the weekly number and percentage of samples positive for influenza virus or RSV vis-à-vis SARS-CoV-2 activity and compared data from the new surveillance platform with existing surveillance platforms. Using data in the new surveillance platform, we analysed early stages of a 2021 out-of-season RSV outbreak and evaluated the capabilities of the new surveillance system with respect to objectives and domains of the WHO mosaic framework.ResultsThe new hospital-laboratory surveillance platform captured the activity of influenza virus and RSV, provided crucial data when outpatient sentinel surveillance was not operational and supported an out-of-season RSV outbreak investigation. The new surveillance platform fulfilled important objectives in all three domains of the mosaic framework and could serve for gathering additional information to fulfil more domain objectives.ConclusionThe new hospital laboratory surveillance platform provided essential data during the COVID-19 pandemic and beyond, fulfilled important domain objectives of the mosaic framework and could be adapted for the surveillance of other viruses.


Assuntos
COVID-19 , Influenza Humana , Pandemias , Infecções por Vírus Respiratório Sincicial , SARS-CoV-2 , Organização Mundial da Saúde , Humanos , COVID-19/epidemiologia , Israel/epidemiologia , Infecções por Vírus Respiratório Sincicial/epidemiologia , Infecções por Vírus Respiratório Sincicial/diagnóstico , Influenza Humana/epidemiologia , Influenza Humana/diagnóstico , Vigilância de Evento Sentinela , Laboratórios Hospitalares/estatística & dados numéricos , Vírus Sincicial Respiratório Humano/isolamento & purificação , Vigilância da População/métodos
2.
Pediatr Nephrol ; 36(6): 1511-1514, 2021 06.
Artigo em Inglês | MEDLINE | ID: mdl-33387020

RESUMO

BACKGROUND: Beta-2 microglobulin (ß2mG) is a low-molecular-weight protein that is almost exclusively eliminated through the kidneys. It is freely filtered in the glomeruli and almost completely reabsorbed and degraded in the proximal tubules. Normal urinary ß2mG levels are very low (between 0.04 and 0.22 mg/L). No reference values are known in infants and young children. METHODS: Urinary ß2mG levels were measured in 103 healthy term neonates during the first week of life by nephelometric technology. RESULTS: The average level of urinary ß2mG was 0.65 mg/L (95% confidence interval between 0 and 10.8 mg/L). There was a minor difference between male and female neonates but it did not reach statistical significance. There was no effect of the gestational week, birth weight, or weight loss in the first week of life, on urinary ß2mG levels. CONCLUSIONS: First-week urinary ß2mG levels in healthy term infants were higher than adult levels. Incomplete maturation of kidney tubules in neonates could be a possible explanation. These can now be used in clinical practice and further studies that assess the degree of proximal tubular function in health and disease. Graphical abstract.


Assuntos
Urinálise , Microglobulina beta-2 , Creatinina , Feminino , Humanos , Recém-Nascido , Rim , Glomérulos Renais , Túbulos Renais , Masculino , Valores de Referência , Microglobulina beta-2/urina
3.
Pediatr Nephrol ; 27(7): 1097-102, 2012 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-22350370

RESUMO

BACKGROUND: Three patients with Dent's disease presented with complaints of impaired night vision or xerophthalmia and were found to have severely decreased serum retinol concentrations. Retinol, bound to its carrier retinol-binding protein (RBP), is filtered at the glomerulus and reabsorbed at the proximal tubule. We hypothesized that urinary loss of retinol-RBP complex is responsible for decreased serum retinol. OBJECTIVE AND METHODS: The study aim was to investigate vitamin A status and RBP in serum and urine of patients with genetically confirmed Dent's disease. RESULTS: Eight patients were studied, three boys had clinical vitamin A deficiency, three had asymptomatic deficiency, and two young men with Dent's disease and impaired renal function had normal retinol values. Serum RBP concentrations were low in patients with vitamin A deficiency and were correlated with vitamin A levels. Urinary RBP concentrations were increased in all patients (2,000-fold), regardless of vitamin A status. This was in contrast to patients with glomerular proteinuria who had only mildly increased urinary RBP with normal serum RBP and vitamin A, and patients with cystinosis with impaired renal function who had massive urinary RBP losses but without a decrease in serum RBP or vitamin A levels. Treatment with vitamin A supplements in patients with retinol deficiency resulted in rapid resolution of ocular symptoms and an increase in serum retinol concentrations. CONCLUSIONS: Vitamin A deficiency is common in patients with Dent's disease and preserved renal function. We therefore recommend screening these patients for retinol deficiency and treating them before visual symptoms develop.


Assuntos
Doença de Dent/complicações , Doença de Dent/metabolismo , Proteínas de Ligação ao Retinol/urina , Deficiência de Vitamina A/etiologia , Deficiência de Vitamina A/metabolismo , Criança , Pré-Escolar , Canais de Cloreto/genética , Análise Mutacional de DNA , Doença de Dent/fisiopatologia , Humanos , Masculino , Mutação , Cegueira Noturna/etiologia , Vitamina A/uso terapêutico , Vitamina A/urina , Deficiência de Vitamina A/fisiopatologia , Vitaminas/uso terapêutico
4.
Kidney Blood Press Res ; 34(2): 116-24, 2011.
Artigo em Inglês | MEDLINE | ID: mdl-21311195

RESUMO

INTRODUCTION: We tested the hypothesis that urinary and serum neutrophil gelatinase-associated lipocalins (NGAL) early after non-cardiac major surgery predict postoperative acute kidney injury (AKI), complications and mortality. METHODS: We studied 74 patients undergoing orthopedic, vascular and abdominal surgery lasting ≥2 h. NGAL was measured in preoperative, as well as 2- and 6-hour postoperative samples. The primary outcome was AKI. Secondary outcome was postoperative infection and death. RESULTS: 10 patients (13.5%) developed AKI, 19 (26%) reached secondary outcomes, of whom 5 (7%) died. Serum NGAL was significantly higher in patients with diabetes and chronic kidney disease (CKD). No significant correlation was detected between serum or urine NGAL and subsequent development of AKI. Urine NGAL at 6 h and serum NGAL at 2 and 6 h were strongly correlated with postoperative infection and death (p = 0.004, p = 0.013 and p = 0.001, respectively). CONCLUSIONS: Our data suggest that in the general surgical population, NGAL could serve as a potent early biomarker for postoperative infection, and that the presence of CKD and diabetes mellitus is associated with higher levels of NGAL and may influence its predictive value.


Assuntos
Proteínas de Fase Aguda/análise , Lipocalinas/análise , Complicações Pós-Operatórias/diagnóstico , Complicações Pós-Operatórias/mortalidade , Valor Preditivo dos Testes , Proteínas Proto-Oncogênicas/análise , Injúria Renal Aguda/etiologia , Proteínas de Fase Aguda/urina , Idoso , Biomarcadores/sangue , Biomarcadores/urina , Diabetes Mellitus , Feminino , Humanos , Lipocalina-2 , Lipocalinas/sangue , Lipocalinas/urina , Masculino , Pessoa de Meia-Idade , Proteínas Proto-Oncogênicas/sangue , Proteínas Proto-Oncogênicas/urina , Insuficiência Renal Crônica , Taxa de Sobrevida
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA